RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY.

Manabe, Ayumu; Shimada, Hiroyuki; Hattori, Takayuki; Nakashizuka, Hiroyuki; Yuzawa, Mitsuko

Manabe, Ayumu; Shimada, Hiroyuki; Hattori, Takayuki; Nakashizuka, Hiroyuki; Yuzawa, Mitsuko.

Affiliation

Manabe A; Department of Ophthalmology, School of Medicine, Nihon University, Chiyodaku, Japan.

Retina ; 35(9): 1800-7, 2015 Sep.

Article in En | MEDLINE | ID: mdl-25932549

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Bevacizumab/therapeutic use; Diabetic Retinopathy/surgery; Premedication; Retinal Neovascularization/drug therapy; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Vitrectomy; Adult; Aged; Aged, 80 and over; Diabetic Retinopathy/diagnosis; Diabetic Retinopathy/physiopathology; Double-Blind Method; Electrocoagulation; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Intravitreal Injections; Male; Middle Aged; Prospective Studies; Retinal Neovascularization/diagnosis; Retinal Neovascularization/physiopathology; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A/metabolism; Visual Acuity/physiology; Vitreous Body/metabolism; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Premedication / Vitrectomy / Retinal Neovascularization / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor A / Diabetic Retinopathy / Bevacizumab Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Retina Year: 2015 Type: Article Affiliation country: Japan

Fulltext

XML

PubMed Links

Search on Google